Indo Amines Limited (INDOAMIN)

Loading page…

Indo Amines Limited (INDOAMIN) · mywealthgrid

About

Indo Amines Limited operates in specialty chemicals (Materials sector). With market cap ₹943.8 Cr and recent standalone revenues of ₹268–₹374 Cr per quarter, it is a mid-cap player showing profitability (ROE 22.37%) with recent operating margins expanding to 14.1% (Jun 2026).

Face value: ₹5

Market cap

₹991 Cr

P/E

12.2×

P/B

2.5×

Dividend yield

0.4%

ROE

22.4%

ROCE

29%

Debt / equity

0.79

OPM

10.6%

EPS (TTM)

₹11.2

Book value

₹54.1

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Operating margin volatility: OPM ranged from 9.11% (Dec 2025) to 14.1% (Jun 2026) within one year—verify exposure to raw-material costs and input-price cycles specific to the company's product mix

Stock underperformance: down 6.86% over 1 year despite positive earnings (ROE 22.37%)—investigate whether market senses structural headwinds or valuation risks

Institutional absence: FII 0.08%, DII 0%—verify depth of research coverage and resilience during market downturns

Debt leverage: D/E 0.79 leaves room for further leverage; verify capex plans, refinancing cycles, and stress scenarios in industry downturns

Generated analysis · source review pending

Growth drivers

Revenue growth: Jun 2026 revenue ₹367–₹374 Cr vs. Dec 2025 ₹268–₹277 Cr shows quarterly growth—verify whether trend is seasonal or structural and driven by end-market demand

Operating margin expansion: OPM improved from 9.11% (Dec 2025) to 14.1% (Jun 2026)—verify whether gains reflect cost control, pricing power, or product-mix shifts and persistence

Earnings acceleration: Jun 2026 EPS ₹4.17–₹4.19 up from Mar 2026 ₹2.73–₹2.77 reflects both revenue and margin gains

Cash generation: consistent dividend history (2022–2025) indicates stable operational cash flow—verify reinvestment rate and capex plans to assess funding for future growth

Generated analysis · source review pending

1,161 historical price candles were omitted because the exchange source has not been verified.

₹136.5-6.1%1Y

Quick read

rule-based

Pros

+Strong return on equity of 19.7% (3-yr avg)
+High return on capital employed of 27.3%
+Profit CAGR of 16.2% over the last 5 years
+Revenue CAGR of 16.5% over the last 5 years

Cons

−Low dividend payout of 4.5% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

66/100

Business quality: 52
Growth: 61
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	302	359	528	479	541	786	945	944	1,079	1,160
COGS	3	0	19	4	351	544	655	661	731	768
Gross profit	—	—	510	—	190	242	290	283	348	391
	263	318	454	432	128	190	202	203	247	269
	36	41	55	42	61	52	87	79	101	123
OPM %	11.9%	11.4%	10.5%	8.8%	11.4%	6.6%	9.2%	8.4%	9.4%	10.6%
Depreciation	12	12	15	20	11	14	17	15	17	21
Interest	4	8	10	11	9	14	17	22	22	24
	3	4	7	7	8	10	4	16	15	29
Profit before tax	23	25	38	18	49	35	57	58	77	106
Tax	7	9	13	6	12	11	16	15	21	27
Tax %	28.9%	36.1%	33.6%	30.1%	23.5%	33.2%	28%	26.3%	27.4%	25.2%
	16	16	25	13	37	23	41	43	56	79
PAT margin %	5.4%	4.5%	4.8%	2.7%	6.9%	2.9%	4.3%	4.5%	5.2%	6.8%
EPS (₹)	4.9	4.7	7.1	3.4	10.7	3.3	5.8	6.1	7.7	10.8
EPS adjusted (₹)	2.5	2.4	3.6	1.8	5.3	3.3	5.8	6.1	7.7	10.9
	20.4%	21.4%	14.1%	29.2%	10.3%	15.3%	8.7%	8.3%	6.5%	4.6%
Annual report	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	33	33	35	35	35	35	35	35	36	36
Reserves	19	48	88	100	127	152	190	228	281	356
Minority interest	—	—	—	—	—	0	0	0	1	1
	32	63	94	94	148	188	232	217	284	311
	83	102	126	133	142	179	139	153	177	193
Total equity & liabilities	167	246	343	362	453	555	597	633	779	897
	51	—	—	95	125	182	198	209	265	325
CWIP	2	5	8	24	54	22	21	23	35	31
Investments	0	—	—	0	0	0	0	2	3	3
	113	241	335	338	274	350	379	400	476	539
Total assets	167	246	343	362	453	555	597	633	779	897

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	96.5%	—	35.1%	30.8%	30.6%	30%	32.2%	33.7%
EBITDA margin %	10.5%	8.8%	11.4%	6.6%	9.2%	8.4%	9.4%	10.6%
EBIT margin %	7.7%	4.7%	9.3%	4.9%	7.4%	6.8%	7.8%	8.7%
PAT margin %	4.8%	2.7%	6.9%	2.9%	4.3%	4.5%	5.2%	6.8%
Working capital
Receivable days	81	73	89	78	72	84	90	89
Inventory days	1,225	68	91	82	76	63	70	85
Payable days	0	—	108	84	58	65	64	64
NWC days	1,306	—	72	76	90	82	96	110
Leverage
Current ratio	—	—	1.12	1.08	1.21	1.3	1.26	1.3
Debt to EBITDA	1.7	2.22	2.41	3.6	2.66	2.73	2.81	2.53
Debt to equity	0.76	0.69	0.91	1	1.03	0.82	0.9	0.79
Interest coverage	4.9	2.7	6.3	3.5	4.3	3.6	4.5	5.5
Asset turnover	1.54	1.32	1.19	1.42	1.58	1.49	1.39	1.29
Return ratios
Return on assets %	7.4%	3.5%	8.3%	4.2%	6.8%	6.8%	7.2%	8.8%
Return on capital employed %	21.3%	10.4%	22.7%	21.3%	28.1%	26%	26.9%	29%
Return on equity %	20.5%	9.5%	23%	12.3%	18.1%	16.3%	17.6%	20.2%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	66.87%	66.76%	66.76%	66.76%	57.25%	57.25%	58.37%	58.42%	58.42%	58.42%	58.42%	58.42%
	0%	0.1%	0.05%	0%	0.01%	0.16%	0.11%	0.03%	0%	0%	0.02%	0.08%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	33.13%	33.14%	33.19%	33.24%	42.74%	42.59%	41.52%	41.55%	41.58%	41.58%	41.56%	41.5%
No. of shareholders	—	—	—	—	—	—	—	—	35,591	34,675	33,816	34,114

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Indo Amines Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

12 announcementsExport CSV

21 Jul 2026, 9:34 pmCompany Update

Announcement Under Regulation 30 (LODR)

General PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	96.5%	—	35.1%	30.8%	30.6%	30%	32.2%	33.7%
EBITDA margin %	10.5%	8.8%	11.4%	6.6%	9.2%	8.4%	9.4%	10.6%
EBIT margin %	7.7%	4.7%	9.3%	4.9%	7.4%	6.8%	7.8%	8.7%
PAT margin %	4.8%	2.7%	6.9%	2.9%	4.3%	4.5%	5.2%	6.8%
Working capital
Receivable days	81	73	89	78	72	84	90	89
Inventory days	1,225	68	91	82	76	63	70	85
Payable days	0	—	108	84	58	65	64	64
NWC days	1,306	—	72	76	90	82	96	110
Leverage
Current ratio	—	—	1.12	1.08	1.21	1.3	1.26	1.3
Debt to EBITDA	1.7	2.22	2.41	3.6	2.66	2.73	2.81	2.53
Debt to equity	0.76	0.69	0.91	1	1.03	0.82	0.9	0.79
Interest coverage	4.9	2.7	6.3	3.5	4.3	3.6	4.5	5.5
Asset turnover	1.54	1.32	1.19	1.42	1.58	1.49	1.39	1.29
Return ratios
Return on assets %	7.4%	3.5%	8.3%	4.2%	6.8%	6.8%	7.2%	8.8%
Return on capital employed %	21.3%	10.4%	22.7%	21.3%	28.1%	26%	26.9%	29%
Return on equity %	20.5%	9.5%	23%	12.3%	18.1%	16.3%	17.6%	20.2%

2 disclosures

Person	Deal	Shares	Value	Holding	Filed
Core Chemicals LLPOther	SellMarket Sale	11,500	₹16.6 L	0.32% → 0.31%	13 Sept 20257(2)
CORE CHEMICALS LLPOther	SellMarket Sale	5,000	₹7.42 L	0.39% → 0.38%	5 Sept 20257(2)

Disclosed under SEBI’s insider-trading regulations, which require a filing only above ₹10 lakh in a quarter — smaller dealings are in no disclosure. Holdings are the filer’s own percentages, not recomputed.

28 deals · 2 Jan 2024 – 4 Dec 2024

Date	Client	Type	Venue	Side	Quantity	Price	Value
4 Dec 2024	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	3,66,712	₹199.01	₹7.30 Cr
4 Dec 2024	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	3,58,984	₹198.81	₹7.14 Cr
9 Sept 2024	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	8,60,184	₹232.99	₹20.04 Cr
9 Sept 2024	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	8,33,443	₹232.67	₹19.39 Cr
9 Sept 2024	AAKRAYA RESEARCH LLP	Bulk	NSE	Buy	6,13,704	₹232.11	₹14.24 Cr
9 Sept 2024	AAKRAYA RESEARCH LLP	Bulk	NSE	Sell	6,13,704	₹232.24	₹14.25 Cr
9 Sept 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	6,02,035	₹229.66	₹13.83 Cr
9 Sept 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	6,02,035	₹229.74	₹13.83 Cr
9 Sept 2024	QE SECURITIES LLP	Bulk	NSE	Sell	5,87,599	₹233.65	₹13.73 Cr
9 Sept 2024	QE SECURITIES LLP	Bulk	NSE	Buy	5,26,197	₹233.16	₹12.27 Cr

1–10 of 28

1 / 3

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Date	Category	Subject	Filing
21 Jul 2026, 9:34 pm	Company Update General	Announcement Under Regulation 30 (LODR)	PDF
17 Jul 2026, 4:20 pm	AGM/EGM Postal Ballot	Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot	PDF
11 Jul 2026, 5:22 pm	Company Update Change in Management	Announcement under Regulation 30 (LODR)-Change in Management	PDF
10 Jul 2026, 11:33 am	Company Update Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	PDF

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	56	35	20	70	91	79
	-50	-33	-30	-27	-89	-71
	-1	7	4	-41	-7	-1
Net cash flow	5	9	-5	2	-5	7
Free cash flow	6	-5	-11	39	-0	0
CFO / Operating profit %	91.6%	67.4%	23.4%	87.7%	90%	64.2%

Indo Amines Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

20

1

1

Compounded sales growth

Compounded profit growth

Return on equity

Indo Amines Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Ratio timeline

Not in the F&O segment

No fund holdings on record

Announcements

Quarterly record

Annual reports

Dividends20

Board meetings1

Stock splits1

Insider dealing

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

20

1

1